US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eterna Therapeutics Inc.

4.35

-0.2200-4.81%

Post-market: 4.350.00000.00%16:10 EDT

Volume:29.18K

Turnover:129.60K

Market Cap:7.10M

PE:-0.23

High:4.65

Open:4.57

Low:4.26

Close:4.57

52wk High:71.50

52wk Low:3.18

Shares:1.63M

Float Shares:1.22M

Volume Ratio:0.84

T/O Rate:2.40%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-18.6059

EPS(LYR):-55.8903

ROE:-320.72%

ROA:-105.57%

PB:2.22

PE(LYR):-0.08

Loading ...

Overview Company News Filings

Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study

Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer

Ernexa Therapeutics plans ERNA-101 investigational new drug submission for Q3

Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:42 PM

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:38 AM

Ernexa Therapeutics announces annual shareholder meeting

Ernexa Q1 net loss narrows 32.87% to $5.51 million; no revenue

Ernexa Therapeutics to join Virtual Investor Closing Bell event

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101

Ernexa Therapeutics initiated with a Buy at Brookline

Ernexa Therapeutics announces new ERNA-101 preclinical data

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM

Ernexa reports ERNA-101 plus PD-1 blockade clears tumors in ovarian cancer models

NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM

Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split

Ernexa Therapeutics authorizes 1-for-10 to 1-for-25 reverse stock split to meet Nasdaq bid rule

Ernexa Therapeutics files draft information statement for potential reverse stock split

Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/ERNA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ERNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ERNA\",,,,,undefined,":{"symbol":"ERNA","market":"US","secType":"STK","nameCN":"Eterna Therapeutics Inc.","latestPrice":4.35,"timestamp":1788292800000,"preClose":4.57,"halted":0,"volume":29183,"hourTrading":{"tag":"盘后","latestPrice":4.35,"preClose":4.35,"latestTime":"16:10 EDT","volume":111,"amount":482.84999999999997,"timestamp":1788293404827,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04814004376367628,"floatShares":1216200,"shares":1632400,"eps":-18.605883,"marketStatus":"Post-Mkt","change":-0.22,"latestTime":"09-01 16:11:07 EDT","open":4.57,"high":4.65,"low":4.26,"amount":129602.44132989999,"amplitude":0.085339,"askPrice":4.35,"askSize":528,"bidPrice":4.25,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-18.605883,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"listingDate":465451200000,"exchange":"NASDAQ","adjPreClose":4.57,"preHourTrading":{"tag":"盘前","latestPrice":4.57,"preClose":4.57,"latestTime":"07:40 EDT","volume":520,"amount":2376.4,"timestamp":1788262853068,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.35,"preClose":4.35,"latestTime":"16:10 EDT","volume":111,"amount":482.84999999999997,"timestamp":1788293404827,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.836702},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ERNA\",,,,,undefined,":{"symbol":"ERNA","floatShares":1216200,"roa":"-105.57%","roe":"-320.72%","lyrEps":-55.89028,"volumeRatio":0.836702,"shares":1632400,"dividePrice":0,"high":4.65,"amplitude":0.085339,"preClose":4.57,"low":4.26,"week52Low":3.1829,"pbRate":"2.22","psRate":"7100.94","week52High":71.4975,"institutionHeld":0.0303,"latestPrice":4.35,"committee":-0.681529,"eps":-18.605883,"divideRate":0,"volume":29183,"delay":0,"ttmEps":-18.605883,"open":4.57,"prevYearClose":30,"prevWeekClose":4.57,"prevMonthClose":4.57,"prevQuarterClose":6.65,"fiveDayClose":4.925,"twentyDayClose":4.42,"sixtyDayClose":7.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ERNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ERNA","fiscalQuarterEnding":"2026/06","expectedEps":-3.3,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-3.4},{"market":"US","date":"2026-05-11","symbol":"ERNA","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-6.95},{"market":"US","date":"2026-05-04","symbol":"ERNA","defaultRemindTime":1777901400000,"type":"split","dateTimestamp":1777867200000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2026-03-13","symbol":"ERNA","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773374400000,"reportTimeType":"post","actualEps":-0.01},{"market":"US","date":"2025-11-07","symbol":"ERNA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ERNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ERNA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1780113600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ERNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ERNA","date":"2026-08-31","current":-0.237291,"percent":0.304348,"low":-19.9703,"twenty":-0.709225,"median":-0.467843,"eighty":-0.284944,"high":-0.075385,"avg":-1.189388,"sd":3.08716,"marketCap":7460118},"quantilePoints":[{"date":"2021-09-03","current":-18.663096,"twenty":-36.032611,"median":-25.754795,"eighty":-19.707771,"marketCap":612995760},{"date":"2021-09-10","current":-19.308823,"twenty":-34.735027,"median":-25.393264,"eighty":-19.132429,"marketCap":634204896},{"date":"2021-09-17","current":-18.82059,"twenty":-33.788214,"median":-24.972717,"eighty":-19.025333,"marketCap":618168720},{"date":"2021-09-24","current":-14.930477,"twenty":-33.300028,"median":-24.618554,"eighty":-18.843094,"marketCap":490396608},{"date":"2021-10-01","current":-14.394995,"twenty":-32.77883,"median":-24.013514,"eighty":-18.637897,"marketCap":472808544},{"date":"2021-10-08","current":-13.103541,"twenty":-32.344818,"median":-22.959864,"eighty":-18.095512,"marketCap":430390272},{"date":"2021-10-15","current":-14.410745,"twenty":-31.986036,"median":-21.866106,"eighty":-17.513386,"marketCap":473325840},{"date":"2021-10-22","current":-14.190252,"twenty":-31.934562,"median":-21.542932,"eighty":-16.458173,"marketCap":466083696},{"date":"2021-10-29","current":-13.41853,"twenty":-31.706074,"median":-21.40929,"eighty":-15.371461,"marketCap":440736192},{"date":"2021-11-05","current":-14.914727,"twenty":-31.586644,"median":-21.186556,"eighty":-15.157269,"marketCap":489879312},{"date":"2021-11-12","current":-3.671231,"twenty":-31.462605,"median":-20.919274,"eighty":-14.943076,"marketCap":428840912},{"date":"2021-11-19","current":-3.038568,"twenty":-31.405239,"median":-20.812361,"eighty":-14.741483,"marketCap":354938716},{"date":"2021-11-26","current":-2.744513,"twenty":-31.300997,"median":-20.402528,"eighty":-14.53674,"marketCap":320589808},{"date":"2021-12-03","current":-2.30343,"twenty":-31.246626,"median":-20.10623,"eighty":-14.410745,"marketCap":269066446},{"date":"2021-12-10","current":-2.36135,"twenty":-31.005605,"median":-19.708035,"eighty":-14.269,"marketCap":275832140},{"date":"2021-12-17","current":-2.241055,"twenty":-30.381057,"median":-19.542356,"eighty":-14.143004,"marketCap":261780314},{"date":"2021-12-23","current":-2.223233,"twenty":-30.316041,"median":-19.293073,"eighty":-13.742968,"marketCap":259698562},{"date":"2021-12-31","current":-1.857892,"twenty":-30.105321,"median":-19.009584,"eighty":-13.387031,"marketCap":217022646},{"date":"2022-01-07","current":-1.71532,"twenty":-30.045341,"median":-18.896839,"eighty":-13.031093,"marketCap":200368630},{"date":"2022-01-14","current":-1.434632,"twenty":-28.912363,"median":-18.82059,"eighty":-3.425295,"marketCap":167581036},{"date":"2022-01-21","current":-1.189586,"twenty":-28.520385,"median":-18.663096,"eighty":-2.991341,"marketCap":138956946},{"date":"2022-01-28","current":-1.127211,"twenty":-28.335341,"median":-18.328147,"eighty":-2.757879,"marketCap":131670814},{"date":"2022-02-04","current":-1.069291,"twenty":-28.244568,"median":-18.048867,"eighty":-2.58501,"marketCap":124905120},{"date":"2022-02-11","current":-1.015826,"twenty":-28.078924,"median":-17.710641,"eighty":-2.393429,"marketCap":118659864},{"date":"2022-02-18","current":-0.984638,"twenty":-27.856384,"median":-17.11965,"eighty":-2.241055,"marketCap":115016798},{"date":"2022-02-25","current":-0.993549,"twenty":-27.75309,"median":-16.710164,"eighty":-2.200065,"marketCap":116057674},{"date":"2022-03-04","current":-0.850977,"twenty":-27.614098,"median":-15.749448,"eighty":-2.151056,"marketCap":99403658},{"date":"2022-03-11","current":-0.85837,"twenty":-27.309643,"median":-15.418709,"eighty":-1.947891,"marketCap":100267205},{"date":"2022-03-18","current":-0.907292,"twenty":-26.980094,"median":-15.253341,"eighty":-1.74829,"marketCap":105981916},{"date":"2022-03-25","current":-0.92953,"twenty":-26.787741,"median":-15.11947,"eighty":-1.632451,"marketCap":108579512},{"date":"2022-04-01","current":-0.889502,"twenty":-26.66879,"median":-14.961976,"eighty":-1.329484,"marketCap":103903840},{"date":"2022-04-08","current":-0.778315,"twenty":-26.504298,"median":-14.772982,"eighty":-1.217209,"marketCap":90915860},{"date":"2022-04-14","current":-0.729392,"twenty":-26.367676,"median":-14.741483,"eighty":-1.191368,"marketCap":85201148},{"date":"2022-04-22","current":-0.581341,"twenty":-26.136985,"median":-14.583989,"eighty":-1.092459,"marketCap":71240380},{"date":"2022-04-29","current":-0.492264,"twenty":-25.851203,"median":-14.489492,"eighty":-1.070182,"marketCap":60324516},{"date":"2022-05-06","current":-0.435255,"twenty":-25.737579,"median":-14.40287,"eighty":-1.023845,"marketCap":53338362},{"date":"2022-05-13","current":-0.374027,"twenty":-25.613626,"median":-14.363496,"eighty":-1.003351,"marketCap":45835141},{"date":"2022-05-20","current":-0.336474,"twenty":-25.324668,"median":-14.190252,"eighty":-0.973054,"marketCap":41233242},{"date":"2022-05-27","current":-0.315424,"twenty":-25.040182,"median":-14.143004,"eighty":-0.944652,"marketCap":38653651},{"date":"2022-06-03","current":-0.285326,"twenty":-24.999779,"median":-13.954011,"eighty":-0.925082,"marketCap":34965238},{"date":"2022-06-10","current":-0.295218,"twenty":-24.945654,"median":-13.631147,"eighty":-0.907292,"marketCap":36177474},{"date":"2022-06-17","current":-0.229723,"twenty":-24.790712,"median":-13.387031,"eighty":-0.898397,"marketCap":28151440},{"date":"2022-06-24","current":-0.269573,"twenty":-24.652986,"median":-13.371281,"eighty":-0.866375,"marketCap":33034854},{"date":"2022-07-01","current":-0.27255,"twenty":-24.610668,"median":-12.922422,"eighty":-0.837611,"marketCap":30906602},{"date":"2022-07-08","current":-0.361389,"twenty":-24.58853,"median":-3.657865,"eighty":-0.813005,"marketCap":40980844},{"date":"2022-07-15","current":-0.294291,"twenty":-23.901199,"median":-3.368266,"eighty":-0.76942,"marketCap":33372004},{"date":"2022-07-22","current":-0.270675,"twenty":-23.193912,"median":-2.989559,"eighty":-0.706884,"marketCap":30693968},{"date":"2022-07-29","current":-0.247008,"twenty":-22.984675,"median":-2.922728,"eighty":-0.592592,"marketCap":28010185},{"date":"2022-08-05","current":-0.267786,"twenty":-22.74049,"median":-2.697731,"eighty":-0.525082,"marketCap":30366397},{"date":"2022-08-12","current":-0.314274,"twenty":-22.158822,"median":-2.615307,"eighty":-0.485701,"marketCap":33536542},{"date":"2022-08-19","current":-0.260857,"twenty":-21.865619,"median":-2.45714,"eighty":-0.412611,"marketCap":27836330},{"date":"2022-08-26","current":-0.220505,"twenty":-21.788831,"median":-2.36135,"eighty":-0.368972,"marketCap":23530288},{"date":"2022-09-02","current":-0.209424,"twenty":-21.621334,"median":-2.247738,"eighty":-0.348362,"marketCap":22347891},{"date":"2022-09-09","current":-0.190516,"twenty":-21.507294,"median":-2.232144,"eighty":-0.335714,"marketCap":20330168},{"date":"2022-09-16","current":-0.17238,"twenty":-21.439583,"median":-2.18759,"eighty":-0.325246,"marketCap":18394802},{"date":"2022-09-23","current":-0.126956,"twenty":-21.411072,"median":-2.163086,"eighty":-0.314749,"marketCap":13547563},{"date":"2022-09-30","current":-0.136107,"twenty":-21.371871,"median":-2.143037,"eighty":-0.307812,"marketCap":14524070},{"date":"2022-10-07","current":-0.127397,"twenty":-21.272086,"median":-1.958139,"eighty":-0.305326,"marketCap":13594623},{"date":"2022-10-14","current":-0.113064,"twenty":-21.165173,"median":-1.857892,"eighty":-0.296303,"marketCap":12065155},{"date":"2022-10-21","current":-0.100605,"twenty":-21.047569,"median":-1.717548,"eighty":-0.292372,"marketCap":10735693},{"date":"2022-10-28","current":-0.097022,"twenty":-20.919274,"median":-1.661856,"eighty":-0.287257,"marketCap":10353326},{"date":"2022-11-04","current":-0.080484,"twenty":-20.912146,"median":-1.470275,"eighty":-0.277075,"marketCap":8588555},{"date":"2022-11-11","current":-0.089304,"twenty":-20.865817,"median":-1.30097,"eighty":-0.268501,"marketCap":9529766},{"date":"2022-11-18","current":-0.334689,"twenty":-20.676938,"median":-1.229684,"eighty":-0.270014,"marketCap":9385362},{"date":"2022-11-25","current":-0.346231,"twenty":-20.459549,"median":-1.211863,"eighty":-0.27105,"marketCap":9708996},{"date":"2022-12-02","current":-0.346231,"twenty":-20.384709,"median":-1.189586,"eighty":-0.27293,"marketCap":9708996},{"date":"2022-12-09","current":-1.003766,"twenty":-20.299179,"median":-1.104934,"eighty":-0.275762,"marketCap":28147614},{"date":"2022-12-16","current":-0.687461,"twenty":-20.187787,"median":-1.087112,"eighty":-0.281392,"marketCap":19277783},{"date":"2022-12-23","current":-0.627125,"twenty":-19.928386,"median":-1.071519,"eighty":-0.283392,"marketCap":17585850},{"date":"2022-12-30","current":-0.58873,"twenty":-19.76073,"median":-1.058152,"eighty":-0.285326,"marketCap":16509165},{"date":"2023-01-06","current":-0.62164,"twenty":-19.718574,"median":-1.029192,"eighty":-0.286526,"marketCap":17432038},{"date":"2023-01-13","current":-0.850185,"twenty":-19.707683,"median":-1.011371,"eighty":-0.287688,"marketCap":23840875},{"date":"2023-01-20","current":-0.895893,"twenty":-19.644625,"median":-1.003766,"eighty":-0.287904,"marketCap":25122643},{"date":"2023-01-27","current":-0.884923,"twenty":-19.530298,"median":-0.989094,"eighty":-0.289577,"marketCap":24815018},{"date":"2023-02-03","current":-0.870296,"twenty":-19.378121,"median":-0.971272,"eighty":-0.290932,"marketCap":24404853},{"date":"2023-02-10","current":-0.745054,"twenty":-19.289924,"median":-0.957065,"eighty":-0.293011,"marketCap":20892810},{"date":"2023-02-17","current":-0.694793,"twenty":-19.163928,"median":-0.92953,"eighty":-0.294847,"marketCap":19483378},{"date":"2023-02-24","current":-0.667349,"twenty":-19.056832,"median":-0.925082,"eighty":-0.295274,"marketCap":18713805},{"date":"2023-03-03","current":-0.674663,"twenty":-18.996984,"median":-0.917925,"eighty":-0.295584,"marketCap":18918888},{"date":"2023-03-10","current":-0.642538,"twenty":-18.956278,"median":-0.91174,"eighty":-0.296303,"marketCap":18018062},{"date":"2023-03-17","current":-0.638095,"twenty":-18.902185,"median":-0.908794,"eighty":-0.297808,"marketCap":17893474},{"date":"2023-03-24","current":-0.688365,"twenty":-18.856603,"median":-0.907778,"eighty":-0.300802,"marketCap":16919331},{"date":"2023-03-31","current":-0.709225,"twenty":-18.83004,"median":-0.905069,"eighty":-0.30391,"marketCap":17432038},{"date":"2023-04-06","current":-0.705053,"twenty":-18.792241,"median":-0.899191,"eighty":-0.305155,"marketCap":17329496},{"date":"2023-04-14","current":-0.682107,"twenty":-18.675695,"median":-0.895893,"eighty":-0.305841,"marketCap":16765518},{"date":"2023-04-21","current":-0.670748,"twenty":-18.656796,"median":-0.888836,"eighty":-0.305955,"marketCap":16486310},{"date":"2023-04-28","current":-0.615289,"twenty":-18.579515,"median":-0.884923,"eighty":-0.306454,"marketCap":15123199},{"date":"2023-05-05","current":-0.681327,"twenty":-18.35397,"median":-0.875781,"eighty":-0.30726,"marketCap":16746347},{"date":"2023-05-12","current":-0.599864,"twenty":-18.284505,"median":-0.868468,"eighty":-0.310367,"marketCap":14744066},{"date":"2023-05-19","current":-0.69109,"twenty":-18.235446,"median":-0.861071,"eighty":-0.314018,"marketCap":14250274},{"date":"2023-05-26","current":-0.488159,"twenty":-18.045717,"median":-0.853841,"eighty":-0.314279,"marketCap":10065837},{"date":"2023-06-02","current":-0.55461,"twenty":-18.033118,"median":-0.850185,"eighty":-0.314299,"marketCap":11436056},{"date":"2023-06-09","current":-0.527518,"twenty":-17.907896,"median":-0.837611,"eighty":-0.315424,"marketCap":10877428},{"date":"2023-06-16","current":-0.569945,"twenty":-17.513386,"median":-0.832175,"eighty":-0.317417,"marketCap":11752260},{"date":"2023-06-23","current":-0.644063,"twenty":-17.513386,"median":-0.831793,"eighty":-0.320326,"marketCap":13280581},{"date":"2023-06-30","current":-0.572526,"twenty":-17.355892,"median":-0.82774,"eighty":-0.322914,"marketCap":11805488},{"date":"2023-07-07","current":-0.590391,"twenty":-17.066102,"median":-0.803551,"eighty":-0.324567,"marketCap":12173866},{"date":"2023-07-14","current":-0.66704,"twenty":-16.82356,"median":-0.782762,"eighty":-0.327297,"marketCap":13754360},{"date":"2023-07-21","current":-0.744904,"twenty":-16.647166,"median":-0.776828,"eighty":-0.327511,"marketCap":15359929},{"date":"2023-07-28","current":-0.711057,"twenty":-16.278629,"median":-0.757656,"eighty":-0.328261,"marketCap":14661997},{"date":"2023-08-04","current":-0.750414,"twenty":-15.787247,"median":-0.753246,"eighty":-0.329188,"marketCap":15473546},{"date":"2023-08-11","current":-0.703186,"twenty":-15.661251,"median":-0.750388,"eighty":-0.332171,"marketCap":14499687},{"date":"2023-08-18","current":-0.600041,"twenty":-15.532105,"median":-0.744379,"eighty":-0.334793,"marketCap":13038897},{"date":"2023-08-25","current":-0.560205,"twenty":-15.39981,"median":-0.742386,"eighty":-0.335461,"marketCap":12173244},{"date":"2023-09-01","current":-0.607511,"twenty":-15.324213,"median":-0.734672,"eighty":-0.336537,"marketCap":13201207},{"date":"2023-09-08","current":-0.580123,"twenty":-15.324213,"median":-0.729424,"eighty":-0.336725,"marketCap":12606071},{"date":"2023-09-15","current":-0.522858,"twenty":-15.239166,"median":-0.7268,"eighty":-0.337894,"marketCap":11361695},{"date":"2023-09-21","current":-0.512898,"twenty":-15.176168,"median":-0.724917,"eighty":-0.339521,"marketCap":11145281},{"date":"2023-09-29","current":-0.562694,"twenty":-15.144669,"median":-0.721172,"eighty":-0.343293,"marketCap":12227348},{"date":"2023-10-06","current":-0.525347,"twenty":-15.103721,"median":-0.714743,"eighty":-0.344552,"marketCap":11415798},{"date":"2023-10-13","current":-0.502939,"twenty":-15.031273,"median":-0.713021,"eighty":-0.346231,"marketCap":10928868},{"date":"2023-10-19","current":-0.49796,"twenty":-15.002924,"median":-0.710141,"eighty":-0.346231,"marketCap":10820662},{"date":"2023-10-23","current":-0.43696,"twenty":-14.993474,"median":-0.709225,"eighty":-0.346231,"marketCap":9495130},{"date":"2023-11-01","current":-0.351037,"twenty":-14.955676,"median":-0.709225,"eighty":-0.345391,"marketCap":7628025},{"date":"2023-11-10","current":-0.273878,"twenty":-14.921027,"median":-0.709037,"eighty":-0.340114,"marketCap":5951364},{"date":"2023-11-17","current":-0.31245,"twenty":-14.82968,"median":-0.707356,"eighty":-0.335,"marketCap":6250555},{"date":"2023-11-24","current":-0.265215,"twenty":-14.760382,"median":-0.706616,"eighty":-0.328346,"marketCap":5305370},{"date":"2023-12-01","current":-0.243416,"twenty":-14.741483,"median":-0.705095,"eighty":-0.324798,"marketCap":4869303},{"date":"2023-12-08","current":-0.392171,"twenty":-14.703684,"median":-0.703916,"eighty":-0.324798,"marketCap":7844979},{"date":"2023-12-15","current":-0.489537,"twenty":-14.640686,"median":-0.702088,"eighty":-0.326602,"marketCap":9792699},{"date":"2023-12-22","current":-0.462491,"twenty":-14.593438,"median":-0.69638,"eighty":-0.32727,"marketCap":9251666},{"date":"2023-12-29","current":-0.497624,"twenty":-14.53674,"median":-0.694793,"eighty":-0.327285,"marketCap":9954468},{"date":"2024-01-05","current":-0.530106,"twenty":-14.508391,"median":-0.69077,"eighty":-0.327321,"marketCap":10604248},{"date":"2024-01-12","current":-0.473309,"twenty":-14.489492,"median":-0.689289,"eighty":-0.327844,"marketCap":9468079},{"date":"2024-01-19","current":-0.375943,"twenty":-14.464293,"median":-0.687461,"eighty":-0.328346,"marketCap":7520360},{"date":"2024-01-26","current":-0.476041,"twenty":-14.420194,"median":-0.685956,"eighty":-0.329362,"marketCap":9522723},{"date":"2024-02-02","current":-0.462491,"twenty":-14.404445,"median":-0.684214,"eighty":-0.33092,"marketCap":9251666},{"date":"2024-02-09","current":-0.43274,"twenty":-14.394995,"median":-0.681717,"eighty":-0.332801,"marketCap":8656529},{"date":"2024-02-16","current":-0.430035,"twenty":-14.382395,"median":-0.679793,"eighty":-0.334897,"marketCap":8602426},{"date":"2024-02-23","current":-0.411103,"twenty":-14.344597,"median":-0.675577,"eighty":-0.335461,"marketCap":8223703},{"date":"2024-03-01","current":-0.421921,"twenty":-14.25325,"median":-0.673579,"eighty":-0.336537,"marketCap":8440116},{"date":"2024-03-08","current":-0.538193,"twenty":-14.190252,"median":-0.670748,"eighty":-0.337157,"marketCap":10766017},{"date":"2024-03-15","current":-0.593665,"twenty":-14.183952,"median":-0.669178,"eighty":-0.339125,"marketCap":11875676},{"date":"2024-03-22","current":-0.581708,"twenty":-14.155604,"median":-0.667349,"eighty":-0.341102,"marketCap":12604448},{"date":"2024-03-28","current":-0.559311,"twenty":-14.143004,"median":-0.66704,"eighty":-0.341102,"marketCap":12119141},{"date":"2024-04-05","current":-0.574292,"twenty":-14.095756,"median":-0.664588,"eighty":-0.343083,"marketCap":12443761},{"date":"2024-04-12","current":-0.564304,"twenty":-13.954011,"median":-0.659122,"eighty":-0.344132,"marketCap":12227348},{"date":"2024-04-19","current":-0.536838,"twenty":-13.765017,"median":-0.655936,"eighty":-0.346231,"marketCap":11632211},{"date":"2024-04-26","current":-0.433391,"twenty":-13.654771,"median":-0.651731,"eighty":-0.346231,"marketCap":9390711},{"date":"2024-05-03","current":-0.426974,"twenty":-13.607523,"median":-0.643822,"eighty":-0.346642,"marketCap":9251666},{"date":"2024-05-10","current":-0.539335,"twenty":-13.41853,"median":-0.641752,"eighty":-0.349508,"marketCap":11686314},{"date":"2024-05-17","current":-0.479627,"twenty":-13.387031,"median":-0.635906,"eighty":-0.351037,"marketCap":10982971},{"date":"2024-05-24","current":-0.470176,"twenty":-13.387031,"median":-0.634777,"eighty":-0.351664,"marketCap":10766558},{"date":"2024-05-31","current":-0.432373,"twenty":-13.374431,"median":-0.63384,"eighty":-0.351664,"marketCap":9900905},{"date":"2024-06-07","current":-0.481989,"twenty":-13.220087,"median":-0.632737,"eighty":-0.352354,"marketCap":11037075},{"date":"2024-06-14","current":-0.467813,"twenty":-13.13504,"median":-0.628835,"eighty":-0.352526,"marketCap":10712455},{"date":"2024-06-21","current":-0.464624,"twenty":-12.958646,"median":-0.624821,"eighty":-0.35433,"marketCap":10639415},{"date":"2024-06-28","current":-0.413471,"twenty":-12.813751,"median":-0.623177,"eighty":-0.356135,"marketCap":9468079},{"date":"2024-07-05","current":-0.415834,"twenty":-7.29926,"median":-0.621325,"eighty":-0.358737,"marketCap":9522182},{"date":"2024-07-12","current":-0.458362,"twenty":-3.655192,"median":-0.61996,"eighty":-0.360781,"marketCap":10496042},{"date":"2024-07-15","current":-0.484352,"twenty":-3.649845,"median":-0.617625,"eighty":-0.361085,"marketCap":11091178},{"date":"2024-08-02","current":-0.406407,"twenty":-3.644499,"median":-0.615289,"eighty":-0.361389,"marketCap":9306310},{"date":"2024-08-09","current":-0.434759,"twenty":-3.439552,"median":-0.612499,"eighty":-0.367214,"marketCap":9955550},{"date":"2024-08-16","current":-0.391318,"twenty":-3.368266,"median":-0.609386,"eighty":-0.373509,"marketCap":9360317},{"date":"2024-08-23","current":-0.420723,"twenty":-3.038568,"median":-0.605511,"eighty":-0.374027,"marketCap":10063693},{"date":"2024-08-30","current":-0.413937,"twenty":-2.998469,"median":-0.605021,"eighty":-0.37459,"marketCap":9901376},{"date":"2024-09-06","current":-0.380008,"twenty":-2.984212,"median":-0.602531,"eighty":-0.375672,"marketCap":9089787},{"date":"2024-09-13","current":-0.346079,"twenty":-2.962826,"median":-0.599952,"eighty":-0.366049,"marketCap":8278199},{"date":"2024-09-20","current":-0.285006,"twenty":-2.929857,"median":-0.598858,"eighty":-0.352526,"marketCap":6817340},{"date":"2024-09-27","current":-0.287268,"twenty":-2.797978,"median":-0.594949,"eighty":-0.35095,"marketCap":6871446},{"date":"2024-10-04","current":-0.214863,"twenty":-2.748968,"median":-0.593665,"eighty":-0.348935,"marketCap":5139517},{"date":"2024-10-11","current":-0.242029,"twenty":-2.669663,"median":-0.591669,"eighty":-0.34569,"marketCap":5789329},{"date":"2024-10-18","current":-0.242029,"twenty":-2.647385,"median":-0.587835,"eighty":-0.341464,"marketCap":5789329},{"date":"2024-10-25","current":-0.214908,"twenty":-2.621544,"median":-0.585317,"eighty":-0.338262,"marketCap":5140599},{"date":"2024-10-31","current":-0.248815,"twenty":-2.569862,"median":-0.582161,"eighty":-0.335,"marketCap":5951646},{"date":"2024-11-08","current":-0.244291,"twenty":-2.496793,"median":-0.581341,"eighty":-0.32843,"marketCap":5843435},{"date":"2024-11-15","current":-1.08538,"twenty":-2.454913,"median":-0.581379,"eighty":-0.327844,"marketCap":48769398},{"date":"2024-11-22","current":-0.608498,"twenty":-2.42729,"median":-0.582613,"eighty":-0.32843,"marketCap":27341622},{"date":"2024-11-29","current":-0.485929,"twenty":-2.393429,"median":-0.582613,"eighty":-0.329362,"marketCap":21834253},{"date":"2024-12-06","current":-0.362332,"twenty":-2.344648,"median":-0.581379,"eighty":-0.33092,"marketCap":16280646},{"date":"2024-12-13","current":-0.331346,"twenty":-2.313128,"median":-0.577612,"eighty":-0.331424,"marketCap":14888391},{"date":"2024-12-20","current":-0.282982,"twenty":-2.283826,"median":-0.574292,"eighty":-0.328346,"marketCap":12715241},{"date":"2024-12-27","current":-0.323686,"twenty":-2.251748,"median":-0.574198,"eighty":-0.327265,"marketCap":14544181},{"date":"2025-01-03","current":-0.421901,"twenty":-2.241055,"median":-0.57259,"eighty":-0.326164,"marketCap":18957269},{"date":"2025-01-10","current":-0.369649,"twenty":-2.241055,"median":-0.571345,"eighty":-0.327041,"marketCap":16609444},{"date":"2025-01-17","current":-0.51337,"twenty":-2.226797,"median":-0.569945,"eighty":-0.32728,"marketCap":23067246},{"date":"2025-01-24","current":-0.66315,"twenty":-2.22056,"median":-0.569945,"eighty":-0.327321,"marketCap":29797333},{"date":"2025-01-31","current":-0.418928,"twenty":-2.200065,"median":-0.568486,"eighty":-0.327844,"marketCap":18823694},{"date":"2025-02-07","current":-0.388743,"twenty":-2.176897,"median":-0.56679,"eighty":-0.32843,"marketCap":17467402},{"date":"2025-02-14","current":-0.32906,"twenty":-2.169769,"median":-0.565812,"eighty":-0.327844,"marketCap":14785642},{"date":"2025-02-21","current":-0.387486,"twenty":-2.164423,"median":-0.564304,"eighty":-0.328346,"marketCap":17410890},{"date":"2025-02-28","current":-0.326773,"twenty":-2.152839,"median":-0.562694,"eighty":-0.328346,"marketCap":14682892},{"date":"2025-03-07","current":-0.33672,"twenty":-2.14571,"median":-0.559758,"eighty":-0.327309,"marketCap":15129852},{"date":"2025-03-14","current":-0.294137,"twenty":-2.093137,"median":-0.557899,"eighty":-0.32643,"marketCap":13100551},{"date":"2025-03-21","current":-0.317418,"twenty":-2.014722,"median":-0.555167,"eighty":-0.324255,"marketCap":14137477},{"date":"2025-03-28","current":-0.265453,"twenty":-1.968386,"median":-0.554317,"eighty":-0.319136,"marketCap":11823027},{"date":"2025-04-04","current":-0.212316,"twenty":-1.894427,"median":-0.551298,"eighty":-0.318025,"marketCap":9456332},{"date":"2025-04-11","current":-0.218415,"twenty":-1.868585,"median":-0.549323,"eighty":-0.314749,"marketCap":9728005},{"date":"2025-04-17","current":-0.2156,"twenty":-1.844526,"median":-0.544579,"eighty":-0.312751,"marketCap":9602617},{"date":"2025-04-25","current":-0.240351,"twenty":-1.776805,"median":-0.542304,"eighty":-0.310623,"marketCap":10704985},{"date":"2025-05-02","current":-0.230263,"twenty":-1.718885,"median":-0.540286,"eighty":-0.30886,"marketCap":10255679},{"date":"2025-05-09","current":-0.226575,"twenty":-1.705518,"median":-0.539305,"eighty":-0.306274,"marketCap":10443761},{"date":"2025-05-16","current":-0.316595,"twenty":-1.66542,"median":-0.538193,"eighty":-0.305841,"marketCap":14593120},{"date":"2025-05-23","current":-0.309018,"twenty":-1.652054,"median":-0.536838,"eighty":-0.305841,"marketCap":14243883},{"date":"2025-05-30","current":-0.30983,"twenty":-1.612847,"median":-0.536779,"eighty":-0.305846,"marketCap":14281301},{"date":"2025-06-06","current":-0.24624,"twenty":-1.505918,"median":-0.535805,"eighty":-0.304984,"marketCap":11350204},{"date":"2025-06-13","current":-0.213769,"twenty":-1.434632,"median":-0.534833,"eighty":-0.299675,"marketCap":9853478},{"date":"2025-06-20","current":-0.420011,"twenty":-1.384731,"median":-0.534341,"eighty":-0.299606,"marketCap":19359969},{"date":"2025-06-27","current":-0.30343,"twenty":-1.315227,"median":-0.533,"eighty":-0.300124,"marketCap":13986283},{"date":"2025-07-03","current":-0.3194,"twenty":-1.271565,"median":-0.530327,"eighty":-0.299282,"marketCap":14722404},{"date":"2025-07-11","current":-0.316206,"twenty":-1.241268,"median":-0.528444,"eighty":-0.299282,"marketCap":14575179},{"date":"2025-07-18","current":-0.325788,"twenty":-1.228793,"median":-0.526496,"eighty":-0.299538,"marketCap":15016852},{"date":"2025-07-25","current":-0.33537,"twenty":-1.217209,"median":-0.525082,"eighty":-0.300012,"marketCap":15458524},{"date":"2025-08-01","current":-0.276281,"twenty":-1.211863,"median":-0.52394,"eighty":-0.299282,"marketCap":12734879},{"date":"2025-08-08","current":-0.263089,"twenty":-1.203843,"median":-0.522858,"eighty":-0.296323,"marketCap":12126844},{"date":"2025-08-15","current":-0.272862,"twenty":-1.19315,"median":-0.519153,"eighty":-0.295411,"marketCap":11925147},{"date":"2025-08-22","current":-0.266789,"twenty":-1.152161,"median":-0.512898,"eighty":-0.29489,"marketCap":11659751},{"date":"2025-08-29","current":-0.242216,"twenty":-1.113845,"median":-0.511174,"eighty":-0.293827,"marketCap":10585826},{"date":"2025-09-05","current":-0.214133,"twenty":-1.104934,"median":-0.511161,"eighty":-0.291556,"marketCap":9358484},{"date":"2025-09-12","current":-0.242216,"twenty":-1.098696,"median":-0.508537,"eighty":-0.289375,"marketCap":10585826},{"date":"2025-09-19","current":-0.222909,"twenty":-1.088449,"median":-0.505792,"eighty":-0.287316,"marketCap":9742029},{"date":"2025-09-26","current":-0.196581,"twenty":-1.086419,"median":-0.504916,"eighty":-0.285541,"marketCap":8591395},{"date":"2025-10-03","current":-0.213256,"twenty":-1.084291,"median":-0.50308,"eighty":-0.284181,"marketCap":9320130},{"date":"2025-10-10","current":-0.235196,"twenty":-1.079499,"median":-0.501915,"eighty":-0.281642,"marketCap":10278991},{"date":"2025-10-17","current":-0.219399,"twenty":-1.074355,"median":-0.49796,"eighty":-0.274488,"marketCap":9588611},{"date":"2025-10-24","current":-0.205357,"twenty":-1.071964,"median":-0.496913,"eighty":-0.272675,"marketCap":8974940},{"date":"2025-10-31","current":-0.312424,"twenty":-1.067509,"median":-0.494391,"eighty":-0.272055,"marketCap":13654182},{"date":"2025-11-07","current":-0.296627,"twenty":-1.059489,"median":-0.491955,"eighty":-0.272253,"marketCap":12963802},{"date":"2025-11-14","current":-0.671869,"twenty":-1.046123,"median":-0.494391,"eighty":-0.272675,"marketCap":12322755},{"date":"2025-11-21","current":-0.547766,"twenty":-1.030974,"median":-0.496913,"eighty":-0.272984,"marketCap":10046577},{"date":"2025-11-28","current":-0.577722,"twenty":-1.01939,"median":-0.497792,"eighty":-0.273309,"marketCap":10596000},{"date":"2025-12-05","current":-0.560604,"twenty":-1.014935,"median":-0.498277,"eighty":-0.273992,"marketCap":10282044},{"date":"2025-12-12","current":-0.633355,"twenty":-1.01048,"median":-0.503,"eighty":-0.274468,"marketCap":11616355},{"date":"2025-12-19","current":-0.539207,"twenty":-1.006285,"median":-0.503194,"eighty":-0.274828,"marketCap":9889600},{"date":"2025-12-26","current":-0.543487,"twenty":-1.003766,"median":-0.505429,"eighty":-0.275958,"marketCap":9968089},{"date":"2026-01-02","current":-0.513531,"twenty":-1.002721,"median":-0.505429,"eighty":-0.276216,"marketCap":9418666},{"date":"2026-01-09","current":-0.59484,"twenty":-0.995331,"median":-0.505779,"eighty":-0.280067,"marketCap":10909955},{"date":"2026-01-16","current":-0.504972,"twenty":-0.98642,"median":-0.505846,"eighty":-0.282271,"marketCap":9261689},{"date":"2026-01-23","current":-0.530648,"twenty":-0.981965,"median":-0.508469,"eighty":-0.282779,"marketCap":9732622},{"date":"2026-01-30","current":-0.513531,"twenty":-0.974836,"median":-0.508537,"eighty":-0.282952,"marketCap":9418666},{"date":"2026-02-06","current":-0.291001,"twenty":-0.970244,"median":-0.508469,"eighty":-0.283495,"marketCap":5337244},{"date":"2026-02-13","current":-0.537298,"twenty":-0.96524,"median":-0.505819,"eighty":-0.282779,"marketCap":9854581},{"date":"2026-02-20","current":-0.544479,"twenty":-0.9593,"median":-0.505819,"eighty":-0.282938,"marketCap":9986281},{"date":"2026-02-27","current":-0.440072,"twenty":-0.953532,"median":-0.505429,"eighty":-0.283324,"marketCap":8071363},{"date":"2026-03-06","current":-0.453363,"twenty":-0.94821,"median":-0.504687,"eighty":-0.284181,"marketCap":8315129},{"date":"2026-03-13","current":-0.456316,"twenty":-0.937536,"median":-0.50308,"eighty":-0.284697,"marketCap":8369300},{"date":"2026-03-20","current":-0.558911,"twenty":-0.927751,"median":-0.504687,"eighty":-0.284821,"marketCap":7871696},{"date":"2026-03-27","current":-0.430982,"twenty":-0.924912,"median":-0.503137,"eighty":-0.28507,"marketCap":6069952},{"date":"2026-04-02","current":-0.435743,"twenty":-0.912227,"median":-0.500792,"eighty":-0.28507,"marketCap":6137007},{"date":"2026-04-10","current":-0.426635,"twenty":-0.908509,"median":-0.497792,"eighty":-0.28507,"marketCap":6008728},{"date":"2026-04-17","current":-0.407798,"twenty":-0.899668,"median":-0.495856,"eighty":-0.28507,"marketCap":5743422},{"date":"2026-04-24","current":-0.395377,"twenty":-0.88899,"median":-0.49189,"eighty":-0.28507,"marketCap":5568496},{"date":"2026-05-01","current":-0.305538,"twenty":-0.876879,"median":-0.487868,"eighty":-0.28507,"marketCap":4303194},{"date":"2026-05-08","current":-0.647508,"twenty":-0.862119,"median":-0.486587,"eighty":-0.28507,"marketCap":9119504},{"date":"2026-05-15","current":-0.978982,"twenty":-0.857464,"median":-0.486587,"eighty":-0.28507,"marketCap":11148652},{"date":"2026-05-22","current":-1.275954,"twenty":-0.857464,"median":-0.486587,"eighty":-0.28507,"marketCap":14530565},{"date":"2026-05-29","current":-1.194031,"twenty":-0.853841,"median":-0.486459,"eighty":-0.285006,"marketCap":13597623},{"date":"2026-06-05","current":-0.838801,"twenty":-0.850185,"median":-0.486587,"eighty":-0.28507,"marketCap":9552267},{"date":"2026-06-12","current":-0.671348,"twenty":-0.835613,"median":-0.486587,"eighty":-0.28507,"marketCap":7645312},{"date":"2026-06-18","current":-0.60324,"twenty":-0.828043,"median":-0.486587,"eighty":-0.28507,"marketCap":6869701},{"date":"2026-06-26","current":-0.757891,"twenty":-0.806071,"median":-0.486459,"eighty":-0.285006,"marketCap":8630864},{"date":"2026-07-02","current":-0.686629,"twenty":-0.782762,"median":-0.486459,"eighty":-0.285006,"marketCap":7819329},{"date":"2026-07-10","current":-0.607337,"twenty":-0.757891,"median":-0.486459,"eighty":-0.285006,"marketCap":6916354},{"date":"2026-07-17","current":-0.729214,"twenty":-0.753616,"median":-0.486459,"eighty":-0.285006,"marketCap":8304290},{"date":"2026-07-24","current":-0.408647,"twenty":-0.744904,"median":-0.484352,"eighty":-0.285006,"marketCap":4653668},{"date":"2026-07-31","current":-0.355389,"twenty":-0.737562,"median":-0.480808,"eighty":-0.284944,"marketCap":4047175},{"date":"2026-08-07","current":-0.446541,"twenty":-0.727283,"median":-0.471357,"eighty":-0.284944,"marketCap":5085211},{"date":"2026-08-14","current":-0.572636,"twenty":-0.721248,"median":-0.467843,"eighty":-0.284944,"marketCap":7019367},{"date":"2026-08-21","current":-0.601933,"twenty":-0.714014,"median":-0.467843,"eighty":-0.284944,"marketCap":7378497},{"date":"2026-08-28","current":-0.630565,"twenty":-0.709591,"median":-0.467843,"eighty":-0.284944,"marketCap":7729466},{"date":"2026-08-31","current":-0.608592,"twenty":-0.709225,"median":-0.467843,"eighty":-0.284944,"marketCap":7460118}],"updateTime":1788287909828},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ERNA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644749918","title":"Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2644749918","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644749918?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:47","pubTimestamp":1781700420,"startTime":"0","endTime":"0","summary":"Lead Cell Therapy Demonstrated Complete Tumor Clearance and 100% Long-Term Survival in Preclinical Ovarian Cancer Models; Multiple Regulatory, Manufacturing and Clinical Catalysts Expected Through 202","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/17/3313445/0/en/Ernexa-Therapeutics-Positioned-to-Become-a-Clinical-Stage-Biotechnology-Company-as-ERNA-101-On-Track-for-Planned-Q3-2026-IND-Submission-and-First-in-Human-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642946026","title":"Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642946026","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642946026?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:41","pubTimestamp":1781008860,"startTime":"0","endTime":"0","summary":"Discussion explores challenges of immunologically “cold” tumors and the potential for scalable engineered cell therapies to expand patient access in oncologyAccess the segmenthere CAMBRIDGE, Mass., Ju","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3308857/0/en/Ernexa-Therapeutics-Highlights-Ovarian-Cancer-Unmet-Need-Hope-for-Patients-and-Potential-Accessibility-Advantages-of-ERNA-101-in-Virtual-Investor-KOL-Connect-Segment-Featuring-Dr-I.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","ERNA","HOPE","BK4139","KOL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638867276","title":"Ernexa Therapeutics plans ERNA-101 investigational new drug submission for Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2638867276","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638867276?lang=en_us&edition=fundamental","pubTime":"2026-05-27 22:06","pubTimestamp":1779890785,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics (ERNA) announced progress in the development of ERNA-101, the company’s therapeutic candidate, achieving multiple milestones th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-plans-erna-101-investigational-new-drug-submission-for-q3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-plans-erna-101-investigational-new-drug-submission-for-q3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638250065","title":"Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2638250065","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638250065?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:11","pubTimestamp":1779883860,"startTime":"0","endTime":"0","summary":"Company remains on track for anticipated IND filing in Q3 2026, marking a transformative step toward becoming a clinical-stage biotechnology companyCAMBRIDGE, Mass., May  27, 2026  (GLOBE NEWSWIRE) --","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/27/3301925/0/en/Ernexa-Therapeutics-Successfully-Completes-Key-Manufacturing-and-IND-Preparation-Milestones-for-ERNA-101-Toward-First-in-Human-Clinical-Development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","IND","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636842404","title":"Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2636842404","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636842404?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:31","pubTimestamp":1779280260,"startTime":"0","endTime":"0","summary":"Discussion highlights significant unmet need in ovarian cancer and the potential of ERNA-101 to address limitations of current therapies Segment also discusses evolving treatment landscape, immunologi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/20/3298486/0/en/Ernexa-Therapeutics-Releases-Virtual-Investor-KOL-Connect-Segment-Featuring-Dr-Elena-Ratner-Highlighting-Ovarian-Cancer-Landscape-and-ERNA-101-Opportunity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","KOL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635399390","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 12:42 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2635399390","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635399390?lang=en_us&edition=fundamental","pubTime":"2026-05-16 00:42","pubTimestamp":1778863378,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 12:42 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nAQN2LZ9P6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634829217","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:38 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2634829217","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634829217?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:38","pubTimestamp":1778593137,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:38 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nAQN2LYMAX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634853253","title":"Ernexa Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2634853253","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634853253?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:11","pubTimestamp":1778533862,"startTime":"0","endTime":"0","summary":"Annual stockholder meeting set for July 1, 2026, held as virtual-only meeting via live audio webcast.Votes scheduled on electing five directors, ratifying Haskell & White LLP as independent registered public accounting firm for fiscal 2026.Ballot also includes adoption of 2026 Omnibus Equity Incentive Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL7ZgSX3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634325826","title":"Ernexa Q1 net loss narrows 32.87% to $5.51 million; no revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2634325826","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634325826?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:03","pubTimestamp":1778533396,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics posted a net loss of USD 5.51 million for the quarter ended March 31, 2026, narrowing from USD 8.2 million a year earlier.Operating loss widened to USD 5.59 million from USD 2.73 million, driven by a USD 2.04 million goodwill impairment charge.Research and development expense climbed to USD 1.92 million from USD 1.31 million on higher ERNA-101 study fees, while general and administrative costs rose to USD 1.63 million from USD 1.42 million.Cash totaled about USD 9.2 million at March 31, 2026, and operating cash outflow was USD 2.26 million; net proceeds from a February public offering were about USD 9.5 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content us","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL7GNBTm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634284759","title":"Ernexa Therapeutics to join Virtual Investor Closing Bell event","url":"https://stock-news.laohu8.com/highlight/detail?id=2634284759","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634284759?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:16","pubTimestamp":1778505414,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics to participate in Virtual Investor Closing Bell event on May 13, 2026 at 4:00 PM ET.Event to feature corporate overview from President and CEO Sanjeev Luther, with Chief Scientific Officer Robert Pierce discussing preclinical ovarian cancer results for ERNA-101, including complete tumor elimination and 100% survival in models when combined with PD-1 blockade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLJ8S7L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","SG9999014013.SGD","SG9999014005.SGD","LU2210149790.SGD","SG9999014039.USD","LU2095319765.USD","BK4112","BK4588","LU2210150020.SGD","BK4139","NDAQ","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","SG9999014021.USD","BK4585","IE00BN0W2W23.USD","ERNA","LU0314104364.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634284706","title":"Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2634284706","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634284706?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:15","pubTimestamp":1778505300,"startTime":"0","endTime":"0","summary":"Moderated discussion with Chief Scientific Officer Dr. Robert Pierce on ovarian cancer and evolving treatment landscape Segment highlights significant unmet need in ovarian cancer and the potential of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3291978/0/en/Ernexa-Therapeutics-Releases-Virtual-Investor-KOL-Connect-Segment-Highlighting-Ovarian-Cancer-Landscape-and-Lead-Candidate-ERNA-101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBB","BK4139","ERNA","KOL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633087171","title":"Ernexa Therapeutics initiated with a Buy at Brookline","url":"https://stock-news.laohu8.com/highlight/detail?id=2633087171","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633087171?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:58","pubTimestamp":1778191090,"startTime":"0","endTime":"0","summary":"Brookline initiated coverage of Ernexa Therapeutics (ERNA) with a Buy rating and $30 price target Ernexa is engineering induced pluripotent stem ce...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-initiated-with-a-buy-at-brookline-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-initiated-with-a-buy-at-brookline-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","LENZ","BK4007","ERNA","BK4539","BRKL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633195262","title":"Ernexa Therapeutics announces new ERNA-101 preclinical data","url":"https://stock-news.laohu8.com/highlight/detail?id=2633195262","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633195262?lang=en_us&edition=fundamental","pubTime":"2026-05-07 12:27","pubTimestamp":1778128039,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics (ERNA) announced new preclinical data demonstrating that its lead cell therapy candidate, ERNA-101, in combination with PD-1 bl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-announces-new-erna-101-preclinical-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-announces-new-erna-101-preclinical-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633139866","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:34 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2633139866","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633139866?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:34","pubTimestamp":1778074485,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:34 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nAQN2LXV0B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633412133","title":"Ernexa reports ERNA-101 plus PD-1 blockade clears tumors in ovarian cancer models","url":"https://stock-news.laohu8.com/highlight/detail?id=2633412133","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633412133?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:33","pubTimestamp":1778070839,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics on May 6, 2026 reported new preclinical results for lead cell therapy candidate ERNA-101 used with PD-1 blockade in ovarian cancer models; results were presented with this announcement.Combination treatment produced complete tumor elimination in tested models, outperforming either approach alone.Studies showed durable long-term survival in treated animals, supporting a potential curative profile in these models.Data point to tumor microenvironment remodeling that could make checkpoint inhibitors more effective in immunologically “cold” tumors.Program positioned to support a first-in-human study in advanced ovarian cancer, with additional combination work underway to broaden potential solid-tumor use.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL1T7bgP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2T93.GBP","BK4585","IE00B3QW5Z07.USD","IE00BKPKM429.USD","ERNA","IE00B64PRP62.GBP","SG9999014013.SGD","NDAQ","SG9999014005.SGD","LU0314104364.USD","LU2095319765.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4112","SG9999014021.USD","LU2210150020.SGD","BK4588","IE00BN0W2W23.USD","BK4139","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632601336","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 03:28 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2632601336","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632601336?lang=en_us&edition=fundamental","pubTime":"2026-05-03 15:28","pubTimestamp":1777793303,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 03:28 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260503:nAQN2LXFUT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631630163","title":"Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2631630163","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631630163?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:00","pubTimestamp":1777554000,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., April  30, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune dise","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/30/3284944/0/en/Ernexa-Therapeutics-Announces-1-for-25-Reverse-Stock-Split.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ERNA","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627568974","title":"Ernexa Therapeutics authorizes 1-for-10 to 1-for-25 reverse stock split to meet Nasdaq bid rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2627568974","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627568974?lang=en_us&edition=fundamental","pubTime":"2026-04-13 21:29","pubTimestamp":1776086944,"startTime":"0","endTime":"0","summary":"Ernexa board adopted reverse stock split resolutions March 26, 2026.Majority shareholder written consent received March 27, 2026, covering 15,552,343 shares, or 53.3% voting power.Action authorizes board to set reverse split ratio within 1-for-10 to 1-for-25.Move targets Nasdaq minimum bid price rule requiring $1 per share for continued listing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL8jsR0s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624447965","title":"Ernexa Therapeutics files draft information statement for potential reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2624447965","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624447965?lang=en_us&edition=fundamental","pubTime":"2026-04-02 05:23","pubTimestamp":1775078626,"startTime":"0","endTime":"0","summary":"Ernexa shareholders authorized board to execute reverse stock split at ratio set between 1-for-10 and 1-for-25.Move targets higher share price to meet Nasdaq $1 minimum bid requirement.Outstanding common shares totaled about 29.2 million as of March 27, 2026.Reverse split would leave authorized common stock unchanged at 150 million shares.Board plans to round up fractional positions to nearest whole share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information con","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL3zT6s4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623580331","title":"Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2623580331","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623580331?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:55","pubTimestamp":1774961700,"startTime":"0","endTime":"0","summary":"Preclinical data demonstrate deep and durable tumor regressions with lead product candidate ERNA-101 in combination with PD-1 Blockade in ovarian cancer IND submission for ERNA-101 expected in Q3 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/31/3265550/0/en/Ernexa-Therapeutics-Highlights-Key-Catalysts-as-Company-Advances-Toward-First-in-Human-Clinical-Trials-in-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","IND","ERNA","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":45,"code":"91000000","status":"200"}]}}